Pfizer's lab study looked at the key N501Y mutation in the new variants and found nothing to suggest it would impact the vaccine. Other mutations, however, have not yet been examined https://t.co/J5wEEjoWSx— BNO News (@BNOFeed) January 8, 2021
Pfizer's lab study looked at the key N501Y mutation in the new variants and found nothing to suggest it would impact the vaccine. Other mutations, however, have not yet been examined https://t.co/J5wEEjoWSx